Posted on Tuesday, November 23rd, 2010 at 7:51 pm.
A molecular diagnostics company, Vermillion Inc, has announced their third quarter reports. There were multiple highlights in the report from the quarter that have improved from the quarter before.
The company saw a volume growth of 74.4 percent over the second quarter of this year. During this quarter the company performed 1,973 OVA1 tests. There total revenue for this quarter was at $413,000 for the three months that ended in September.
Totaling operating expenses also increased in this quarter to $4.0 million, up from $.07 million during the same time last year. The company’s net loss went from $11 million during this period in 2009 to $2.7 million this year.
If you or your business has issues with their financial records, contact the Austin Accounting today with any questions on the topic that you may have.